[Differential aspects in children and adult patients with medulloblastoma]

Zuriñe García Casales1, Aizpea Echebarría Barona, Alejandro Urberuaga Pascual

  • 1Unidad de Oncohematología Pediátrica, Hospital de Cruces, Baracaldo, Vizcaya, Spain.

Medicina Clinica
|August 14, 2009
PubMed

Insights

Medulloblastoma, a common childhood brain tumor, shows high aggressiveness in both children and adults, leading to significant mortality and long-term sequelae in survivors. Multidisciplinary care and monitoring are essential for managing this aggressive cancer.

Area of Science:

  • Neuro-oncology
  • Pediatric oncology
  • Cancer research

Background:

  • Medulloblastoma is the most common malignant brain tumor in children.
  • This study focuses on medulloblastoma, a significant pediatric and adult malignancy.

Purpose of the Study:

  • To analyze the clinical characteristics, treatment outcomes, and long-term sequelae of medulloblastoma patients.
  • To highlight the aggressive nature and mortality rates associated with medulloblastoma.

Main Methods:

  • Retrospective observational cohort study.
  • Inclusion of all medulloblastoma patients diagnosed between 1989-2007.
  • Analysis of tumor site, dissemination, treatment, relapse, sequelae, and survival data.

Main Results:

  • 37 patients (20 male, 17 female) aged 1-48 years were included.
  • High rates of relapse (59.5%) and mortality (56.8% global, 48.6% at 5 years) were observed.
  • 100% of survivors experienced sequelae, primarily cerebellar and ocular; one patient developed secondary tumors.

Conclusions:

  • Medulloblastoma is an aggressive tumor in both children and adults, necessitating aggressive treatment.
  • Long-term monitoring for survivors is crucial to manage sequelae and watch for secondary malignancies.
  • Multidisciplinary treatment approaches are vital for improving outcomes in medulloblastoma patients.
Abstract

Related Concept Videos

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...